Millions of individuals live with substance use disorders (SUDs) or are at risk of fatal overdoses. We need innovative strategies to prevent and treat SUDs to improve and save lives.
- We use translational strategies to develop and test new medications for substance use disorders in preclinical labs and translate these into treatments for humans.
- We draw upon a continuum of expertise from molecular to cellular biology, vaccine development, advanced drug delivery strategies and animal behavioral approaches to define and validate the potential impact on habitual drug use.
- We pull together scientists, clinicians, advocates, clients, civic leaders and other shareholders to combat addiction and serve the health needs of the community.
Marco Pravetoni, PhD
Director, Center for Medication Development for Substance Use Disorders and Overdose